Technique of forceps delivery using UTokyo Naegele forceps

Takeda, Jun; Makino, Shintaro; Itakura, Atsuo; Takeda, Satoru

doi:10.14390/jsshp.hrp2017-004

Cited by 4 publications

(4 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ongoing efforts by journals, industry, associations and others encourage greater reporting transparency 4,24,51 . Several pharmaceutical companies have incorporated the requirement to publish all study results independent of study outcome into their policies [10][11][12][13][14][15][16]40,41 . However, significant hurdles remain.…”

Section: Progress and Future Plansmentioning

confidence: 99%

“…In 2010, the pharmaceutical associations encouraged their members to submit manuscripts for all phase 3 clinical trials 7 . Many pharmaceutical companies have since implemented policies and guidance to promote transparency and credibility: adopting ICMJE authorship criteria; disclosing study sponsor and medical writing support; and providing authors with greater access to trial data [8][9][10][11][12][13][14][15][16] . In 2008, five pharmaceutical companies and the International Society for Medical Publication Professionals (ISMPP) established Medical Publishing Insights & Practices (MPIP), a collaboration to elevate trust, transparency and integrity in publishing industry-sponsored studies.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Transparency and credibility of industry-sponsored clinical trial publications: a survey of journal editors

Mooney

Fay

deCastro

et al. 2019

Current Medical Research and Opinion

View full text Add to dashboard Cite

Objective: To examine how medical journal editors perceive changes in transparency and credibility of industry-sponsored clinical trial publications over a 5 year period (2010 to 2015). Methods: From July to September 2015, a survey link was emailed to journal editors identified from the Thomson Reuters registry. Editors ranked their perception of: a) change in transparency and credibility of industry-sponsored clinical trial publications; b) 8 "Publication Best Practices" and the impact of each on transparency; and c) the importance and adoption of the previously published "10 Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research". Results: Of 510 editors who opened the survey, the analysis pool comprised a total of 293 editors. The majority of respondents reported their location as the US (46%) or EU (45%) and most commonly reported editorial titles were deputy/assistant editor (36%), editor-in-chief (35%) and section editor (24%). More editors reported improved versus worsened transparency (63.5% vs. 6.1%) and credibility (53.2% vs. 10.4%). Best practices that contributed most to improved transparency were "disclosure of the study sponsor" and "registration and posting of trial results". Respondents ranked the importance of nine recommendations as moderate or extremely important, and adoption of all recommendations was ranked minimal to moderate. Conclusions: The 293 editors who responded perceived an improvement in the transparency and credibility of industry-sponsored publications from 2010 to 2015. Confirmation of the importance of 9/10 recommendations by the respondents was encouraging. Yet, low adoption rates suggest that additional work is required by all stakeholders to improve best practices, transparency and credibility.

show abstract

Section: Progress and Future Plansmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Transparency and credibility of industry-sponsored clinical trial publications: a survey of journal editors

Mooney

Fay

deCastro

et al. 2019

Current Medical Research and Opinion

View full text Add to dashboard Cite

show abstract

“…The normal vaginal delivery rate did not change after introduction of forceps delivery. NVD, normal vaginal delivery; CS, cesarean section; VE, vacuum extraction; FD, forceps delivery lecture with forceps delivery videos, [3][4][5] a demonstration, and simulation training experience. After forceps delivery training, the obstetrician began performing forceps delivery in 2016.…”

Section: Dear Editormentioning

confidence: 99%

Effect of introducing forceps delivery at a local primary clinic

Takeda

Ohashi²

2018

Hypertens Res Pregnancy

Self Cite

View full text Add to dashboard Cite

“…After correcting the malrotation and asynclitism, pull the forceps in the same manner as is done with normal forceps. 2) The episiotomy and removal of the forceps that follow are also performed in the same manner as for normal forceps.…”

Section: Traction: Downward-horizontal-upward Traction Episiotomy Amentioning

confidence: 99%